Evaluating the Effectiveness of Panchkarma on Patients with Parkinson s Disease: A Clinical Trial

Evaluate The Efficacy of Panchkarma Protocol in The Management of Kampavata (Parkinson s Disease) An Open Labelled Randomized Controlled Clinical Trial - Nil

Status

Recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/10/095693

Enrollment

Registered

2025-10-08

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G20- Parkinsons disease

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with clinical signs and symptoms of Kampavata(Parkinson s Disease). 2. Controlled diabetes and hypertension cases to be taken with conventional medicine. 3. Preferably freshly diagnosed cases as well as cases of Kampavata(Parkinson s Disease) with a chronicity of less than 10 years with persisting symptoms despite allopathy medications. 4. Patients willing to participate for an interventional study.

Exclusion criteria

Exclusion criteria: Patients unfit for Virechana, Basti and Shirobasti.

Design outcomes

Primary

Measure	Time frame
Changes in Serum Dopamine level.Timepoint: Day 0 (Baseline), After 75 Days of Intervention	—

Secondary

Measure	Time frame
1. Changes in UPDRS score 2. Changes in symptoms like Kampa, Chestasanga (Akinesia and Bradykinesia), Stambha, Avanamana, Vakvikruti and Gatisanga.(As per Assessment Scale mentioned in CRF) Timepoint: Day 0 (Baseline), Day 75, and Day 105(Follow-up)	—

Countries

India

Contacts

Public ContactDr Umakant Gupta

National Institute of Ayurveda, (DU), Jaipur.

gopesh.pk@nia.edu.in8619849011

Outcome results